Copyright
©The Author(s) 2022.
World J Gastrointest Endosc. Jun 16, 2022; 14(6): 376-386
Published online Jun 16, 2022. doi: 10.4253/wjge.v14.i6.376
Published online Jun 16, 2022. doi: 10.4253/wjge.v14.i6.376
Table 1 Demographic and clinical features of the 64 patients analyzed
Parameter | n = 81 | EUS diagnosis, n = 64 | Missed EUS diagnosis, n = 17 | P value |
Male, n (%) | 51 (63) | 43 (67) | 8 (46) | 0.208 |
Age at enrollment, mean ± SD, yr | 61 ± 18 | 62 ± 18 | 59 ± 16 | |
Previous cholecystectomy, n (%) | 19 (23) | 18 (28) | 0 | 0.028 |
Recurrent pancreatitis, n (%) | 14 (17) | 14 (22) | 0 | 0.101 |
One episode, n (%) | 7 (9) | |||
≥ 2 episodes, n (%) | 6 (7) | |||
Amylase, median (range) | 468 (107-4988) | 465 (123-4988) | 500 (107-4753) | 0.861 |
Lipase, median (range) | 777 (87-23840) | 774 (87-23840) | 780 (96-12800) | 0.914 |
Gamma-glutamyl transpeptidase, median (range) | 70 (9-1665) | 70 (9-1665) | 125 (11-640) | 0.707 |
Alkaline phosphatase, median (range) | 78 (32877) | 78 (32-877) | 90 (32-185) | 0.707 |
Direct bilirubin, median (range) | 0.7 (0.2-8.5) | 0.4 (0.2-3) | 0.7 (0.2-8.5) | 0.933 |
Alanine aminotransferase, median (range) | 34 (6-793) | 34 (6-793) | 33 (7-596) | 0.488 |
Aspartate aminotransferase, median (range) | 38 (11-704) | 34 (11-704) | 33 (15-301) | 0.732 |
Abdominal US, n (%) | 72 (89) | 63 (98) | 9 (54) | < 0.001 |
Abdominal CECT, n (%) | 72 (89) | 56 (88) | 16 (94) | 1.000 |
MRCP, n (%) | 32 (39) | 28 (44) | 4 (24) | 0.220 |
EUS findings, n (%) | NA | NA | NA | |
Normal (final IAP diagnosis) | 17 (21) | |||
Biliary | 16 (20) | |||
Microlithiasis / biliary sludge | 9 (11) | |||
Acute on chronic pancreatitis | 25 (31) | |||
Solid or cystic lesions | 11 (14) | |||
Pancreatic adenocarcinoma | 4 (5) | |||
Ampullary adenoma | 2 (3) | |||
BD-IPMN with high-risk stigmata or worrisome features | 5 (6) | |||
Pancreas divisum | 4 (5) | |||
Ductal anomaly | 4 (5) | |||
Autoimmune criteria | 4 (5) |
Table 2 Frequencies of acute pancreatitis etiologies at endoscopic ultrasound according to the type of previous negative exam/s
Type of previous negative exam/s | |||||||
Type of AP etiology at EUS | US | CECT | MRCP | US + CECT | US + MRCP | CECT + MRCP | US + CECT + MRCP |
Biliary; microlithiasis/biliary sludge | 20%; 10% | 16%; 5% | 17%; 17% | 19%; 7% | 18%; 18% | 14%; 14% | 16%; 16% |
Acute on chronic | 37% | 29% | 38% | 32% | 39% | 33% | 37% |
Solid or cystic lesions | 15% | 14% | 17% | 15% | 18% | 19% | 21% |
Pancreas divisum | 3% | 6% | 4% | 5% | 4% | 5% | 5% |
Anomalous pancreaticobiliary junction | 6% | 6% | 4% | 7% | 4% | 5% | 5% |
Autoimmune criteria | 6% | 3% | 4% | 5% | 4% | 5% | 5% |
Idiopathic | 13% | 26% | 16% | 17% | 3% | 9% | 11% |
-
Citation: Mazza S, Elvo B, Conti CB, Drago A, Verga MC, Soro S, De Silvestri A, Cereatti F, Grassia R. Endoscopic ultrasound diagnostic gain over computed tomography and magnetic resonance cholang
iopancreatography in defining etiology of idiopathic acute pancreatitis. World J Gastrointest Endosc 2022; 14(6): 376-386 - URL: https://www.wjgnet.com/1948-5190/full/v14/i6/376.htm
- DOI: https://dx.doi.org/10.4253/wjge.v14.i6.376